Onset of Response With Infliximab vs. Vedolizumab in the Treatment of Bio-Naϊve Inflammatory Bowel Disease: 663Chris Fourment,Timothy E. Ritter,Samantha A. Kuten,Thomas C. Hardin,Lucinda J. Van AnglenAMERICAN JOURNAL OF GASTROENTEROLOGY(2019)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要